{"organizations": [], "uuid": "a83773637f09bbd96b53686aeda9c2b43a6e8807", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Plague-Pipeline-of-Therapeutics-Development-for-2015-Reviewed-in-New-Research-Report-48815-1/", "country": "US", "title": "Plague Pipeline of Therapeutics Development for 2015 Reviewed in New Research Report", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Plague Pipeline of Therapeutics Development for 2015 Reviewed in New Research Report", "spam_score": 0.0, "site_type": "news", "published": "2015-10-12T20:04:00.000+03:00", "replies_count": 0, "uuid": "a83773637f09bbd96b53686aeda9c2b43a6e8807"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Plague-Pipeline-of-Therapeutics-Development-for-2015-Reviewed-in-New-Research-Report-48815-1/", "ord_in_thread": 0, "title": "Plague Pipeline of Therapeutics Development for 2015 Reviewed in New Research Report", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Date:10/12/2015 \nPUNE, India , October 12, 2015 /PRNewswire/ -- \nThe Plague - Pipeline Review, H2 2015 market research report provides data and information that helps strengthen plague R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. \nComplete report on Plague pipeline spread across 62 pages, analyzing 6 companies, 8 drug profiles and supported with 24 tables and 15 figures is now available at http://www.rnrmarketresearch.com/plague-pipeline-review-h2-2015-market-report.html . \nThis report provides comprehensive information on the therapeutic development for Plague, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Plague and special features on late-stage and discontinued projects. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. \nCompanies mentioned in this Plague pipeline H2 2015 review report include Aradigm Corporation, Grifols, S.A., iBio, Inc., Mucosis B.V., Syntiron LLC and Tetraphase Pharmaceuticals Inc. Drug profiles discussed in this report are anthrax + plague vaccine, ARD-3100, ciprofloxacin hydrochloride, plague vaccine, pneumonic plaque vaccine, Small Molecules to Inhibit Yoph Protein Tyrosine Phosphatase for Plague, TP-271 and Yersinia pestis vaccine. Order a copy of Plague - Pipeline Review, H2 2015 market research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=420708 . \nThe report provides a snapshot of the global therapeutic landscape of Plague and reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities. The report reviews key players involved in the therapeutics development for Plague and enlists all their major and minor projects summarizing all the dormant and discontinued pipeline projects. A review of the Plague products under development by companies and universities/research institutes based on information derived from company and industry-specific sources, pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages, a detailed assessment of monotherapy and combination therapy pipeline projects, coverage of the Plague pipeline on the basis of target, MoA, route of administration and molecule type, latest news and deals relating related to pipeline products. \nAnother newly published market research titled Smallpox - Pipeline Review, H2 2015 is a report that provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies and helps identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. The research helps develop strategic initiatives by understanding the focus areas of leading companies, identify and understand important and diverse types of therapeutics under development for Smallpox as well as plan mergers and acquisitions effectively by identifying key players of the most promising pipeline. Devise corrective measures for pipeline projects by understanding Smallpox pipeline depth and focus of Indication therapeutics as well as develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope with the help of this Smallpox pipeline review report of 86 pages available at http://www.rnrmarketresearch.com/smallpox-pipeline-review-h2-2015-market-report.html . \nExplore more reports on Infectious Diseases Therapeutics market at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/infectious-diseases-therapeutics . \nAbout Us: \nRnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. \nContact: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar", "external_links": [], "published": "2015-10-12T20:04:00.000+03:00", "crawled": "2015-10-13T01:50:26.578+03:00", "highlightTitle": ""}